Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Background While exercise training (ET) is an established tool in heart failure (HF), no
research to date has analysed the efficacy of ET in both preserved (HFpEF) and reduced …

Background Age-related clonal hematopoiesis of indeterminate potential (CHIP), defined as
clonally expanded leukemogenic sequence variations (particularly in DNMT3A, TET2 …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background: The cumulative burden and importance of cardiovascular risk factors have
changed over the past decades. Specifically, obesity rates have increased among younger …

Aims This study was designed to evaluate whether survival rates in patients with heart
failure (HF) are better than those in patients with diagnoses of the four most common …

Background: Heart failure (HF) is associated with excess morbidity and mortality for which
noncardiac causes are increasingly recognized. The authors previously described an …

Aims We investigated the sex‐based risk of mortality across the spectrum of left ventricular
ejection fraction (LVEF) in a large cohort of patients in Australia. Methods and results …

Aims To describe trends in incidence and case fatality among younger (18–54 years) and
older (55–84 years) Swedish patients with heart failure (HF). Methods and results Through …

Objectives: This study sought to evaluate the risk of cancer in patients with heart failure (HF)
compared with community controls and to determine the impact of cancer post-HF on …